(Q80381236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Modulating ongoing Th2-cell responses in experimental leishmaniasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

G S Nabors

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

76-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

Role of cytokines in determining T-lymphocyte function

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Visceral leishmaniasis in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

An in Vitro Model for Investigation of Chemotherapeutic Agents in Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2896%2910078-8

7 January 2021

10.1016/S0169-4758(96)10078-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275127%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference